New Releases from NCBI BookshelfWHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of dual-stain cytology to triage women after a positive test for human papillomavirus (HPV) [Internet]. 2nd edition.​WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of dual-stain cytology to triage women after a positive test for human papillomavirus (HPV) [Internet]. 2nd edition.

In 2022, cervical cancer was the fourth most commonly occurring cancer among women globally and also the fourth leading cause of cancer deaths among women, accounting for around 662 000 new cases and around 349 000 deaths. It is the most common cancer in women in 25 countries, many of which are in sub-Saharan Africa. Even while recognizing varying incidence levels, cervical cancer can be eliminated as a public health problem, through the scale-up of the World Health Organization (WHO) Cervical Cancer Elimination Initiative.

​